PlainRecalls
FDA Devices Moderate Class II Ongoing

Amicus Exchange Kit Therapeutics. Component of Amicus Separator multiprocedural apheresis platform

Reported: March 22, 2023 Initiated: February 14, 2023 #Z-1255-2023

Product Description

Amicus Exchange Kit Therapeutics. Component of Amicus Separator multiprocedural apheresis platform

Reason for Recall

Potential for centrifuge packs to develop a stress leak for certain lots of Amicus MNC Apheresis kit and Amicus Exchange kit (Therapeutic Kits) on the Amicus Separator.

Details

Recalling Firm
Fenwal Inc
Units Affected
6,564 units
Distribution
Nationwide distribution. International distribution to France, Korea, Taiwan, Colombia, India, Brazil, Germany, Canada.
Location
Lake Zurich, IL

Frequently Asked Questions

What product was recalled?
Amicus Exchange Kit Therapeutics. Component of Amicus Separator multiprocedural apheresis platform. Recalled by Fenwal Inc. Units affected: 6,564 units.
Why was this product recalled?
Potential for centrifuge packs to develop a stress leak for certain lots of Amicus MNC Apheresis kit and Amicus Exchange kit (Therapeutic Kits) on the Amicus Separator.
Which agency issued this recall?
This recall was issued by the FDA Devices on March 22, 2023. Severity: Moderate. Recall number: Z-1255-2023.